Hi-tech 'Trojan horse' can kill cancer cells: researchers
June 29, 2009
Two women look at prostate cancer cells under a microscope. Australian researchers are set to begin human trials of a tiny nano-cell that acts as a "Trojan horse" against cancer cells, a breakthrough they say may curb the need for debilitating chemotherapy.
Australian researchers are set to begin human trials of a tiny nano-cell that acts as a "Trojan horse" against cancer cells, a breakthrough they say may curb the need for debilitating chemotherapy.
The technology could eventually allow cancer sufferers to receive treatment as outpatients, rather than being hospitalised for lengthy bouts of chemotherapy, according to the researchers.
Himanshu Brahmbhatt from Sydney-based biotechnology company EnGeneIC said the research -- outlined in the journal Nature Biotechnology -- had the potential to reduce the side-effects of cancer treatment and make it cheaper.
Brahmbhatt said the technology allowed medics to target cancer cells without damaging healthy tissue, a major problem with existing chemotherapy treatments.
"Essentially you need to get the drug directly inside the cancer cell and not slug the body," he told the Australian Broadcasting Corporation.
While researchers have been working on using nano-cells against cancer for at least five years, Brahmbhatt said the latest version had proved 100 percent effective treating cancers in mice which were resistant to conventional chemotherapy.
The cells were loaded with anti-cancer medications and deployed in "waves" to combat cancers, he said.
"The first wave of Trojan horses goes in there and disables the resistance mechanisms inside the cancer cell," he said.
"Interestingly, these cancer cells are totally receptive to repeated waves of these Trojan horses.
"We can send in these nano-cells again and again and each time we can load them up with different types of armaments against cancer."
The cells will be tested on long-term cancer patients at three Melbourne hospitals later this year.
Brahmbhatt said the nano-cells used less drugs than conventional treatments, making them cheaper to administer.
The targeted treatment also means they have less side-effects than chemotherapy, he said.
"(Cancer treatment) effectively can change to literally an outpatient therapy, where the patient simply comes in once or twice a week," Brahmbhatt said.
"You can receive the treatment in a very short period of time and you can go about your normal life and not have any of these horrific toxic side effects."
(c) 2009 AFP
-
New 'bubble' targets only cancer cells
Feb 19, 2009 |
not rated yet |
0
-
Breakthrough vaccine to treat chemo-resistant ovarian cancer
Mar 08, 2007 |
not rated yet |
0
-
Scientists develop new drug to outflank cancer resistance
Dec 11, 2007 |
not rated yet |
0
-
Ovarian cancer stem cells identified, characterized
Apr 17, 2008 |
not rated yet |
0
-
Genes identified which predict response to breast cancer treatment
Sep 24, 2007 |
not rated yet |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (30) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (3) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (1) |
0
-
Cancer drugs and Alzheimer's, Oh my!
3 hours ago
-
Squishing cells
3 hours ago
-
Any books/articles for evolutionary stable strategy models in humans?
15 hours ago
-
Science behind the bore feeling?
21 hours ago
-
Homo Sapien vs. Chimpanzee - Divergence Timeline
Feb 09, 2012
-
a single mRNA strand is attached to sevaral ribosomes?
Feb 08, 2012
- More from Physics Forums - Biology
More news stories
'Dark plasmons' transmit energy
Microscopic channels of gold nanoparticles have the ability to transmit electromagnetic energy that starts as light and propagates via "dark plasmons," according to researchers at Rice University.
9 hours ago |
5 / 5 (4) |
0
|
Nanotube therapy takes aim at breast cancer stem cells
Wake Forest Baptist Medical Center researchers have again proven that injecting multiwalled carbon nanotubes (MWCNTs) into tumors and heating them with a quick, 30-second laser treatment can kill them.
Nanotechnology / Bio & Medicine
14 hours ago |
5 / 5 (1) |
0
|
Inspired by steel, nanomanufacturing gets wear-resistant carbide tip
(PhysOrg.com) -- Scientists at the University of Pennsylvania, the University of Wisconsin-Madison and IBM Research - Zurich have fabricated an ultrasharp silicon carbide tip possessing such high strength ...
19 hours ago |
5 / 5 (3) |
1
|
New technology platform for molecule-based electronics
Researchers at the Nano-Science Center at the University of Copenhagen have developed a new nano-technology platform for the development of molecule-based electronic components using the wonder material graphene. At the same ...
Nanotechnology / Nanomaterials
16 hours ago |
5 / 5 (2) |
0
New kind of solar cell could capture significantly more energy than current cells
New solar cells could increase the maximum efficiency of solar panels by over 25%, according to scientists from the University of Cambridge.
Feb 08, 2012 |
4.5 / 5 (11) |
14
|
FDA-approved drug rapidly clears amyloid from the brain, reverses Alzheimer's symptoms in mice
Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer's disease. The researchers' findings, published in the journal Science, show t ...
Hydrogen from acidic water: Researchers develop potential low cost alternative to platinum for splitting water
A technique for creating a new molecule that structurally and chemically replicates the active part of the widely used industrial catalyst molybdenite has been developed by researchers with the Lawrence Berkeley ...
Ultraviolet protection molecule in plants yields its secrets
Lying around in the sun all day is hazardous not just for humans but also for plants, which have no means of escape. Ultraviolet (UV) radiation from the sun can damage proteins and DNA inside cells, leading ...
Soraa LED light may dim 50-watt halogen rivals
(PhysOrg.com) -- Soraa, a Fremont, California company founded in 2008, this week launched its first product, a light that uses LEDS (light emitting diodes). The "Soraa LED MR16 lamp" is the "perfect" replacement ...
Anyone can learn to be more inventive, cognitive researcher says
There will always be a wild and unpredictable quality to creativity and invention, says Anthony McCaffrey, a cognitive psychology researcher at the University of Massachusetts Amherst, because an "Aha moment" is rare and ...
Flexible paper robots
(PhysOrg.com) -- These inexpensive robots can stretch, bend and twist under control, and lift objects up to 120 times their own weight. Being soft, they can apply gentle and even pressure, and adapt to varied ...
Jun 29, 2009
Rank: 5 / 5 (4)
-How did the nano-cells disable the defense mechanisms of the cancer cells?
-Which types of cancer have been successfully treated with this method, and
-How does this approach differ from previous attempts to selectively insert cytotoxins into cancer cells?
Jun 29, 2009
Rank: 4.5 / 5 (2)
Just my humble opinion , of course.
Jun 29, 2009
Rank: not rated yet
I would love to hear the answers to these questions myself.
Jun 29, 2009
Rank: not rated yet
http://blogs.zdne...h/?p=572
"Researchers there have used bacterial cells stripped of reproductive powers to develop receptacles capable of carrying any chemotherapy drug. These 'nano-cells', which are about one-fifth the size of of normal human cells, are then tagged with antibodies, which are attracted to cancerous tumours. Once the nano-cell hits the cancer and attaches, the drug is released directly into the malignant growth."
Jun 29, 2009
Rank: not rated yet
Abstract:
http://www.cell.c...)00090-6
There are links in the top right to the full article. Choose one under "Article Information".
Jun 30, 2009
Rank: not rated yet
http://www.nature...547.html
This is the abstract.. unfortunately, you can't read the whole paper online unless you purchase it or have a subscription to Nature Biotech.
In response to Birger:
The EDVs are targeted to the cancer cells using antibodies. The EDVs themselves are loaded with a chemotheraputic drug and deliver their payload once they get into the cancer cell. That's the standard treatment. The latest paper involves attacking cancer cells which are drug resistant and reversing that using siRNAs before hitting the cells with a second wave of EDVs loaded with chemo.
As for which cancers, quite a number including breast, ovarian, non-Hodgkin's lymphoma, lukemia, to name but a few.
Jun 30, 2009
Rank: not rated yet